Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate
- 1 September 1993
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 27 (1) , 31-37
- https://doi.org/10.1016/0360-3016(93)90418-u
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapyRadiotherapy and Oncology, 1992
- “State of the art” transrectal ultrasound imaging in the assessment of prostatic diseaseThe British Journal of Radiology, 1991
- The correlation of histopathological, microradiographic and ultrasonographic features in disease of the prostate glandThe British Journal of Radiology, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated PatientsJournal of Urology, 1989
- Prostate Biopsy after Definitive Treatment by Interstitial 125 Iodine Implant or External Beam Radiation TherapyJournal of Urology, 1987
- A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United StatesInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Salvage Surgery Following Radical Radiotherapy for Adenocarcinoma of the ProstateJournal of Urology, 1985
- Radiotherapy for Prostatic Carcinoma: Post-Irradiation Prostatic Biopsy and Recurrence Patterns With Long-term FollowupJournal of Urology, 1982
- Radiation injury of the normal and neoplastic prostateThe American Journal of Surgical Pathology, 1982
- Significance of prostatic biopsies after radiation therapy for carcinoma of the prostateThe Prostate, 1982